Journal
EXPERIMENTAL AND THERAPEUTIC MEDICINE
Volume 15, Issue 1, Pages 345-350Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/etm.2017.5429
Keywords
systemic lu-pus erythematosus; long non-coding RNA; growth arrest-specific 5; microRNA-21
Categories
Funding
- key research grant of Wannan Medical College [WK20142F04]
Ask authors/readers for more resources
The present study aimed to assess the expression of growth arrest-specific 5 (GAS5) and microRNA (miR)-21 in systemic lupus erythematosus (SLE), and attempted to explore their association with clinical features. CD4(+) T cells were isolated from peripheral blood of healthy donors and SLE patients by magnetic-activated cell sorting. GAS5 and miR-21 expression levels in cluster of differentiation (CD)4(+) T cells were measured by reverse-transcription quantitative polymerase chain reaction. The results revealed that GAS5 and miR-21 levels were significantly elevated in CD4(+) T cells of patients with SLE compared with those in control subjects (P<0.05). Regarding clinical features, SLE patients with ulceration had higher GAS5 expression levels in CD4(+) T cells than those without ulceration (P<0.05), and the expression of miR-21 was significantly higher in CD4(+) T cells of SLE patients with low levels of complement component 3 (C3) than in those with normal levels of complement C3 (P< 0.05). In conclusion, GAS5 and miR-21 in CD4(+) T cells may serve as potential biomarkers for the diagnosis and monitoring of the progression of SLE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available